Cocrystal Pharma,Inc.是一家生物技术公司。该公司专注于开发抗病毒疗法,抑制引起急性和慢性病毒性疾病的RNA病毒的基本病毒复制功能。该公司通过研究和开发针对病毒复制过程的候选药物,专注于治疗流感病毒、冠状病毒、丙型肝炎病毒(HCV)和诺如病毒感染。该公司使用计算方法,利用共晶结构信息筛选和设计候选产品。该公司的丙型肝炎病毒(HCV)非核苷聚合酶抑制剂CC-31244是用于治疗丙型肝炎感染的NS5B聚合酶的泛基因型抑制剂。该公司的CC-42344是一种用于治疗甲型流感感染的PB2抑制剂。该公司的研发管线还包括用于治疗冠状病毒的CDI-45205。它还开发了由非核苷抑制剂、金属结合抑制剂和药物样片段组成的化学文库。
名称 | 标题 | 任期 | 年龄 |
|---|---|---|---|
| Roger D. Kornberg | Co-Founder, Independent Chairman, Chief Scientist & Chairman of Scientific Advisory Board | 2021 | 79 |
| Steven D. Rubin | Independent Vice Chairman | 2014 | 66 |
| Richard C. Pfenniger | Independent Director | 2021 | 71 |
| Phillip Frost | Independent Director | 2014 | 90 |
| Bob Lehman | Member of Scientific Advisory Board | - | - |
| Michael Levitt | Member of Scientific Advisory Board | - | 79 |
| Gary Schoolnik | Member of Scientific Advisory Board | - | - |
| Roland Strong | Member of Scientific Advisory Board | - | - |
| Christophe Verlinde | Member of Scientific Advisory Board | - | - |
| Baek Kim | Member of Scientific Advisory Board | - | - |
| Fred Hassan | Independent Director | 2023 | 80 |